Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2 Positive Breast Cancer
Interventions: DRUG: Hemay022
Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd